Febrile neutropenia associated with adalimumab in a patient with ulcerative colitis

<p dir="ltr">Adalimumab has become essential for managing various chronic inflammatory diseases, including inflammatory bowel disease (IBD). While hematologic complications of adalimumab therapy are rare, they can have significant clinical implications. This report highlights the imp...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلف الرئيسي: Ma’In Atallah Mohammad Abumuhfouz (21768278) (author)
مؤلفون آخرون: Anas Alsadi (21768281) (author), Waseem Fadhl Umer (21768284) (author), Mhd Baraa Habib (11721774) (author)
منشور في: 2024
الموضوعات:
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
_version_ 1864513543678722048
author Ma’In Atallah Mohammad Abumuhfouz (21768278)
author2 Anas Alsadi (21768281)
Waseem Fadhl Umer (21768284)
Mhd Baraa Habib (11721774)
author2_role author
author
author
author_facet Ma’In Atallah Mohammad Abumuhfouz (21768278)
Anas Alsadi (21768281)
Waseem Fadhl Umer (21768284)
Mhd Baraa Habib (11721774)
author_role author
dc.creator.none.fl_str_mv Ma’In Atallah Mohammad Abumuhfouz (21768278)
Anas Alsadi (21768281)
Waseem Fadhl Umer (21768284)
Mhd Baraa Habib (11721774)
dc.date.none.fl_str_mv 2024-03-27T09:00:00Z
dc.identifier.none.fl_str_mv 10.1002/ccr3.8629
dc.relation.none.fl_str_mv https://figshare.com/articles/journal_contribution/Febrile_neutropenia_associated_with_adalimumab_in_a_patient_with_ulcerative_colitis/29625263
dc.rights.none.fl_str_mv CC BY 4.0
info:eu-repo/semantics/openAccess
dc.subject.none.fl_str_mv Biomedical and clinical sciences
Clinical sciences
Immunology
Pharmacology and pharmaceutical sciences
Adalimumab
Crohn's disease
fever
neutropenia
dc.title.none.fl_str_mv Febrile neutropenia associated with adalimumab in a patient with ulcerative colitis
dc.type.none.fl_str_mv Text
Journal contribution
info:eu-repo/semantics/publishedVersion
text
contribution to journal
description <p dir="ltr">Adalimumab has become essential for managing various chronic inflammatory diseases, including inflammatory bowel disease (IBD). While hematologic complications of adalimumab therapy are rare, they can have significant clinical implications. This report highlights the importance of recognizing and monitoring for neutropenia in patients receiving adalimumab treatment. We also describe the potential mechanisms and management strategies for this adverse event.</p><h2>Other Information</h2><p dir="ltr">Published in: Clinical Case Reports<br>License: <a href="http://creativecommons.org/licenses/by/4.0/" target="_blank">http://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.1002/ccr3.8629" target="_blank">https://dx.doi.org/10.1002/ccr3.8629</a></p>
eu_rights_str_mv openAccess
id Manara2_697bd59c5b287a8770aa8eb57fc1bf7d
identifier_str_mv 10.1002/ccr3.8629
network_acronym_str Manara2
network_name_str Manara2
oai_identifier_str oai:figshare.com:article/29625263
publishDate 2024
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
rights_invalid_str_mv CC BY 4.0
spelling Febrile neutropenia associated with adalimumab in a patient with ulcerative colitisMa’In Atallah Mohammad Abumuhfouz (21768278)Anas Alsadi (21768281)Waseem Fadhl Umer (21768284)Mhd Baraa Habib (11721774)Biomedical and clinical sciencesClinical sciencesImmunologyPharmacology and pharmaceutical sciencesAdalimumabCrohn's diseasefeverneutropenia<p dir="ltr">Adalimumab has become essential for managing various chronic inflammatory diseases, including inflammatory bowel disease (IBD). While hematologic complications of adalimumab therapy are rare, they can have significant clinical implications. This report highlights the importance of recognizing and monitoring for neutropenia in patients receiving adalimumab treatment. We also describe the potential mechanisms and management strategies for this adverse event.</p><h2>Other Information</h2><p dir="ltr">Published in: Clinical Case Reports<br>License: <a href="http://creativecommons.org/licenses/by/4.0/" target="_blank">http://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.1002/ccr3.8629" target="_blank">https://dx.doi.org/10.1002/ccr3.8629</a></p>2024-03-27T09:00:00ZTextJournal contributioninfo:eu-repo/semantics/publishedVersiontextcontribution to journal10.1002/ccr3.8629https://figshare.com/articles/journal_contribution/Febrile_neutropenia_associated_with_adalimumab_in_a_patient_with_ulcerative_colitis/29625263CC BY 4.0info:eu-repo/semantics/openAccessoai:figshare.com:article/296252632024-03-27T09:00:00Z
spellingShingle Febrile neutropenia associated with adalimumab in a patient with ulcerative colitis
Ma’In Atallah Mohammad Abumuhfouz (21768278)
Biomedical and clinical sciences
Clinical sciences
Immunology
Pharmacology and pharmaceutical sciences
Adalimumab
Crohn's disease
fever
neutropenia
status_str publishedVersion
title Febrile neutropenia associated with adalimumab in a patient with ulcerative colitis
title_full Febrile neutropenia associated with adalimumab in a patient with ulcerative colitis
title_fullStr Febrile neutropenia associated with adalimumab in a patient with ulcerative colitis
title_full_unstemmed Febrile neutropenia associated with adalimumab in a patient with ulcerative colitis
title_short Febrile neutropenia associated with adalimumab in a patient with ulcerative colitis
title_sort Febrile neutropenia associated with adalimumab in a patient with ulcerative colitis
topic Biomedical and clinical sciences
Clinical sciences
Immunology
Pharmacology and pharmaceutical sciences
Adalimumab
Crohn's disease
fever
neutropenia